Newsroom Stories

Joshua Yuan at the McKelvey School of Engineering is using quantum physics to develop technology to image photosynthesis in action without disturbing the process. The research has received support from the U.S. Department of Energy.

Physicist Johanna Nagy in Arts & Sciences chases traces of “the beginning of the universe” using a balloon-borne instrument that will be launched in the next few weeks.

School of Medicine scientists have shown that the cancer therapy known as CAR-T can be applied to multiple sclerosis (MS), an autoimmune disease of the nervous system. The findings extend the powerful tool of immunotherapy to autoimmune diseases, a class of diseases that are often debilitating and difficult to treat.

In a new book, “Voicing Politics,” Arts & Sciences’ Margit Tavits uncovers the many ways in which linguistic peculiarities of different languages can have meaningful consequences for political attitudes and beliefs around the world.

A research team that includes School of Medicine and pharmacy scientists has altered the chemical properties of fentanyl. The research holds promise for developing safer opioid drugs that still relieve pain.

Using advanced geochemical analyses, a team of scientists, including Michael Frachetti, professor of archaeology in Arts & Sciences, have uncovered new answers to decades-old questions about trade of tin throughout Eurasia during the Late Bronze Age.

Elinor Harrison, a postdoctoral fellow in physical therapy and in dance, will present a new duet choreographed for twin dance majors Ali and Juli Yaniz as part of “This is Temporary,” the 2022 WashU Dance Theatre concert.

Research from Quing Zhu’s lab at the McKelvey School of Engineering yields a novel method to use ultrasound to enhance machine learning’s ability to accurately diagnose — or rule out — ovarian cancer.

A new study by researchers at Washington University School of Medicine found that undergoing more frequent computed tomography (CT) scans was not associated with improved outcomes following lung cancer surgery.

Researchers at Washington University School of Medicine have discovered a biomarker for a rare, deadly brain disease known as corticobasal degeneration (CBD). The biomarker could accelerate efforts to develop treatments for CBD.